Elena Johnson*
The prognosis for people who are diagnosed with lung cancer has historically been dismal. However, significant developments in detection and therapy over the past ten years have led to the first rises in lung cancer survival rates. The significant developments in palliative care, systemic targeted medicines, curative treatments, and early lung cancer diagnosis are highlighted in this overview. We cover the key studies that support these novel approaches/strategies and where they stand in clinical practice now.
English 
Spanish 
Chinese 
German 
French 
Japanese 
Portuguese 
Hindi